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SERUM and BALF (bronchoalveolar lavage fluid) IL-8
levels and serum levels were investigated in Tox ocara
canis infected  guinea-pigs  and  the role of  IL-5  as a
modulator of cytokine secretion was studied. Serum
levels increased early in infected animals, exceeding
control  levels  4 h  after  infection,  peaked  between
days 6 and 18, and continued to exceed control levels
after 48 days of infection. Serum and BALF IL-8 levels
showed  the  same  profile  as  blood  eosinophilia,
increasing 6 days post-infection and peaking between
days 18 and 24. Treatment of infected animals with
anti-IL-5 Ab suppressed eosinophilia with a parallel
increase in blood IL-8 levels, whereas no change was
found in levels. To support our in vivo observation we
carried out experiments in vitro using guinea-pig LPS-
stimulated  adherent  peritoneal  cells  which  release
large  amounts  of  IL-8  into  the  supernatants.  When
rIL-5 was added to LPS-stimulated cells, 65% inhibi-
tion  of  IL-8  release  into  the  supernatants  was
observed.  Pre-incubation  of  cells  with  anti-IL-5  Ab
prevented  the  inhibition  of  IL-8  release  into  the
supernatants  induced  by  rIL-5.  Our  results  demon-
strate  for  the  first  time  that  TNF-a and  IL-8  are
released concomitant with or after IL-5 in the eosino-
philic inflammation induced by T. canis. Moreover, in
addition to showing that IL-5 is fundamental for the
induction of blood eosinophilia, the present results
suggest that this cytokine may play a new biological
role by acting as modulator of IL-8 secretion.
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Introduction
Eosinophilia has been associated with parasitic dis-
eases,  particularly  when  the  parasites  invade  the
tissue or injure the mucosal surfaces.1 T oxocara canis
is  an  intestinal  parasite  of  dogs  and  is  the  most
common  aetiologic  agent  of  visceral  larva  migrans
syndrome in humans. Beaver et al,2 when describing
this  syndrome,  noted  intense  eosinophilia  which
reached  more  than  90%   of  total  leukocyte  counts.
Despite previous observations that IL-5 participates in
T . canis-induced eosinophilia3 and drives eosinophils
from  the  bone  marrow  to  blood,3 little  is  known
about  the  presence  of  other  cytokines  related  to
eosinophil recruitment and the physiological control
of blood eosinophilia in this parasitic model.
Using the well established guinea-pig model of T .
canis infection,3 we determined the release of two
relevant cytokines, TNF-a and IL-8, and studied their
interaction with  IL-5. This  cytokine  is  an  inducible
glycoprotein produced and secreted by T cells, mast
cells  and  eosinophils,4 which  promotes  the  differ-
entiation and proliferation of eosinophils5 and plays
an essential role in the induction of eosinophilia in
allergic inflammation,6 asthma,7 viruses,8 and helmin-
thic  infection.3,9,10 Anti-IL-5 Ab  treatment  inhibited
blood and tissue eosinophilia.3,10,11 IL-8 is a member
of  the  C-X-C  chemokines  described  as  neutrophil
chemotactic  factor12 which  also  attracts  eosino-
phils.13,14 IL-8 is synthesized by monocytes,12 eosino-
phils,15 and other cells in response to several stim-
ulus. IL-8 is an important mediator of lung disease16
and may be relevant in asthma.17 Finally, TNF-a is an
important  mediator  of  inflammation  produced  in
response to various stimuli such as bacteria,18 fungi,19
and  allergen  challenge.20 TNF-a is  also  involved  in
eosinophil recruitment21,22 and induces in vivo and
in vitro IL-8 release.23,24
In the present study we first investigated whether
TNF-a and IL-8 are released during T . canis-induced
eosinophilic inflammation in guinea-pigs. Since dur-
ing the course of infection we observed a sequential
release  of TNF-a and  IL-8  in  connection  with  IL-5
release,3 we also examined the relationship between
IL-5  levels  and  IL-8  and TNF-a release  in  vivo by
inducing IL-5 depletion with anti-IL-5 Ab. To corrobo-
rate  the  results  obtained  in  vivo we  carried  out
experiments in vitro studying the effect of rIL-5 on IL-
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peritoneal cells.
Material and Methods
Reagents, MAbs and cytokines
Human rIL-5 was a kind gift from Dr S. Poole, National
Institute for Biological Standards and Control (NIBSB),
UK. The rat MAb TRFK-5 was initially provided by Dr
P . Minoprio, Institut Pasteur, Paris, and later raised and
purified by Mrs M. A. Nahori (Institut Pasteur, Paris).
Irrelevant  antibody  was  rat  IgG  against  total  anti-
human IgG. LPS from E. coli 0111:B4 was from Sigma
(Sigma Chemical Co., St Louis, MO, USA) and thiogly-
collate  medium  was  from  Difco  (USA).  Cytokines
were  measured  using  commercially  available  ELISA
kits (Quantikine—R & D System, Minneapolis, MN).
The kits were sensitive to human IL-8 and TNF-a levels
of 5pg/ml and 4.8pg/ml, respectively.
Animals
Outbred  albino  female  guinea-pigs  weighing
300–400g were obtained from the University of S˜ ao
Paulo and kept in the animal house of the Department
of  Parasitology,  Microbiology  and  Immunology,
School of Medicine of Ribeir˜ ao Preto, under routine
conditions.
Infection of animals
T .  canis eggs  were  obtained  from  gravid  female
worms recovered from dogs. The eggs were removed
from the uterus, washed and allowed to develop to
the infective stage in shallow dishes containing 0.5%
formalin  at  37°C.3 Guinea-pigs  were  infected  with
1ml saline containing 500 T . canis eggs, by gastric
intubation using a metal cannula, under light ether
anaesthesia. Guinea-pigs receiving 1ml of saline orally
were used as control.
Blood cell determination and serum collection
Blood was obtained and cell counts were performed
as  previously  described.3 Briefly,  guinea-pigs  were
anaesthetized  with  sodium  pentobarbitone  (30mg/
kg, i.v.) and blood samples were collected by cardiac
puncture. A sample was immediately added to a tube
containing Turk solution and total cell counts were
carried  out  using  a  Neubauer  chamber.  Another
sample was used to prepare a smear, and differential
counts were obtained using Rosenfeld-stained slices.
Five ml of blood was allowed to coagulate and the
serum separated and kept at –20°C.
Bronchoalveolar lavage fluid (BALF) and femur
flushing liquid
Infected  and  non-infected  guinea-pigs  killed  with
overdose  of  sodium  pentobarbitone  and  5ml  of
phosphate-buffered  saline  (PBS)  containing  0.5%
sodium  citrate  (PBS/SC)  were  instilled  through  a
polyethylene  cannula  introduced into  the  trachea.3
The  cell-free  supernatants  were  recovered  imme-
diately and kept at –20°C. Femur flushing liquid was
collected from guinea-pigs using 5ml of PBS/SC, and
cell free fluid was stored at –20°C.
BAL, femur flushing liquid and serum cytokine
determinations
Serum, BALF and femur flushing fluid were used to
measure IL-8-like and TNF-a like concentration using
human ELISA kits.
TRFK-5 treatments in vivo
T . canis-infected guinea-pigs were injected i.p. with
TRFK-5, an anti-IL-5 Ab, only once (2mg/animal) at
the time of infection (protocol A, PrA). Another group
of infected animals received several i.p. anti-IL-5 Ab
treatments at different intervals (1mg/animal) at the
time of infection followed by 0.3mg/animal on days
1, 3, 12 and 17 thereafter (protocol B, PrB). A group of
T . canis infected guinea-pigs was treated with irrele-
vant Ab using PrB. A group  of infected guinea-pigs
without  treatment  and  a  group  of  non  infected
animals were used for comparison. All animals were
sacrificed  18  days  after  administration  of  T .  canis
eggs.
Preparation of adherent peritoneal cells and
IL-8 generation in vitro
Peritoneal exudate cells were obtained from outbred
female guinea-pigs (300g) 4 days after an i.p. injection
of  10ml  of  3%   thioglycollate  (Difco).  Guinea-pigs
were sacrificed with an overdose of sodium pento-
barbitone  and  the  cells  were  harvested  from  the
peritoneal cavities by injection of 20ml of RPMI 1640
(Gibco  BRL,  Grand  Island)  containing  10U/ml  of
heparin  without  FCS. The  peritoneal  exudate  con-
sisted  of  95–98%   mononuclear  cells  (macrophages
and lymphocytes) on the basis of morphology deter-
mined by light microscopy examination of Rosenfeld-
stained  cytospin  preparations. The  cells  were  har-
vested from four individual guinea-pigs and added to
separate  plates  (2  3 106 cells/well,  in  a  24-well
polypropylene plate from Costar, Cambridge, MA; cell
viability 90–95%, as determined by Trypan blue) and
incubated for 2h at 37°C, at 5% CO2, in RPMI 1640
culture  medium  supplemented  with  50U/ml  pen-
icillin, 50m g/ml streptomycin and 2mmol/ml 2-mer-
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times with medium to remove non-adherent cells. The
monolayers of adherent cells were pre-incubated with
RPMI  1640  medium  supplemented with  antibiotics
and 10% FCS with or without anti-IL-5 Ab (0.17ng/ml
or  17ng/ml)  over  a  period  of  15min.  Thereafter,
medium or rIL-5 (0.5ng/ml or 10ng/ml) was added to
the culture, and after 15min of incubation the cells
were  stimulated  or  not  with  LPS  (500ng/ml). The
plates were incubated for an additional 6–8h at 37°C,
5% CO2. The cell-free supernatants  were  collected,
separated and kept at –20°C until the measurement of
IL-8. The results were expressed as cytokine concen-
tration (pg/ml) in supernatants of LPS-stimulated cells
submitted to different treatments minus the concen-
tration of cytokine released by cells incubated with
medium alone. All the experiments were performed
under aseptic conditions.
Statistical analysis
Data  are  presented  as  the  mean  ±  SEM  and  were
analysed statistically by the Student’s two-tailed t-test
for  differences  between  infected  and  non-infected
animals, or between infected untreated and treated
guinea-pigs. A P < 0.05 value was considered to be
statistically significant. In vitro results were analysed
statistically by the Student’s two-tailed t-test and by
ANOVA test.
Results
Blood eosinophil counts and serum TNF-a and
IL-8 levels during T. canis infection
As  shown  in  Fig.  1,  T .  canis-infected  guinea-pigs
developed  blood  eosinophilia  (Fig.  1A)  and  had
increased circulating TNF-a (Fig. 1B) and IL-8 (Fig. 1C)
levels. Blood eosinophilia increased significantly on
day 12 and peaked by day 18 post-infection. Serum
TNF-a levels increased 4h after egg inoculation and
became  significantly  higher  24h  later  were  still
increased by day 3, peaked between days 6 and 18
and remained above control levels up to 48 days post-
infection. TNF-a in the serum of non-infected animals
was  8 ±  1pg/ml,  n =  9.  Serum  IL-8  concentration
showed the same profile as blood eosinophilia, but
increased significantly only on day 12 post-infection,
reaching  a  peak  between  days  18  and  24  and
decreasing by day 48. In this set of experiments, no IL-
8 was detectable in the serum of non-infected guinea-
pigs (n = 7).
BALF and femur flushing liquid IL-8 levels
BALF and bone marrow IL-8 levels were also deter-
mined during T . canis infection, and the results are
shown in Fig. 2. BALF IL-8 levels were not detectable
on day 3 but  increased significantly on day 6 post-
infection (41.3 ± 14.5pg/ml), and reached a plateau
between days 12 and 24 (72.2 ± 8.4pg/ml on day 12,
72.5 ± 21.8pg/ml on day 18; and 64.1 ± 10.9pg/ml on
day  24)  post-infection.  BALF  IL-8  in  non-infected
guinea-pigs and femur flushing liquid IL-8 in T . canis
infected guinea-pigs were not detectable at any of the
times studied.
Effects of in vivo anti-IL-5 Ab treatment on IL-8
secretion
Having  demonstrated  that  eosinophilia  in  T .  canis-
infected guinea-pigs is correlated with IL-5,3 and IL-8
secretion, we investigated the effect of IL-5 inhibition
on TNF-a and IL-8 release into the serum of infected
guinea-pigs. The i.p. injections of anti-IL-5 Ab (TRFK-5)
into T . canis-infected guinea-pigs using the PrA (single
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FIG. 1. Blood eosinophil counts (A) and serum TNF-a (B), and IL-8 (C) levels in T. canis-infected guinea-pigs sacrificed at
different times post-infection (n = 4–5 per day). Asterisks indicate a significant difference between infected (j ) and non-
infected animals (m ). * P < 0.05 and ** P < 0.01.dose)  and  PrB  (several  doses)  protocols  inhibited
blood eosinophil counts by 97%  to 99%, as shown in
Table 1. When the animals were treated with a single
dose of anti-IL-5 Ab, PrA, a 159%  increase in IL-8 was
observed  in  serum  (Table  1,  range  101–234%  of
control; n = 6 animals, obtained in two different sets
of  experiments).  Moreover,  when  infected  animals
were  treated  with  PrB,  eosinophilia  was  also  sup-
pressed and serum IL-8 levels were increased by 216%
(Table 1, range 128–329% of control, n = 6, obtained
in two sets of experiments). By contrast, no alteration
in serum TNF-a concentration was observed whatever
the  treatment  (Table  1,  T .  canis-infection  without
treatment  n = 7, obtained from two set  of  experi-
ments; anti-IL-5 Ab given once n = 3; several anti-IL-5
Ab injections n = 5). Infected animals treated with
irrelevant Ab presented nonsignificant differences in
serum IL-8 (n = 3) and TNF-a levels (n = 3). Serum IL-8
and TNF-a levels of non-infected animals were 14 ± 10
and 8 ± 1pg/ml, receptively; n = 6, obtained from two
sets of experiments.
IL-5 downregulates IL-8 secretion in vitro
In order to clarify the in vivo experiments, in vitro
experiments were performed using adherent perito-
neal cells stimulated with LPS, a potent inductor of IL-
8 secretion.12 IL-8 was determined in supernatants of
LPS-stimulated  guinea-pig  adherent  peritoneal  cells
pre-incubated with or without rIL-5. The amounts of
IL-8 released by adherent peritoneal cells stimulated
with LPS (500ng/ml) were increased in the absence
of rIL-5 (Fig. 3, column 1). In the presence of rIL-5
(0.5ng/ml or 10ng/ml; Fig. 3, columns 2 and 5) LPS-
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Table 1. Blood eosinophil counts and serum TNF and IL-8 levels in T. canis infected guinea-pig untreated or treated with
TRFK-5
Treatment Eosinophil counts TNF (pg/ml) IL-8 (pg/ml)
Untreateda 12.2 ± 5.3© 116.7 ± 12.0©© 106.0 ± 14.0
©©
Irrelevant Aba 13.3 ± 4.5 85.5 ± 8.5 121.0 ± 9.0
TRFK-5 (PrA)a 0.2 ± 0.2* 118.5 ± 10.0 274.4 ± 42.0**
TRFK-5 (PrB)a 0.01 ± 0.01* 134.0 ± 12.0 336.0 ± 45.0***
Non infected 0.96 ± 0.41 8.0 ± 1.0 28.0 ± 14.0
aThe animals were sacrificed 18 days after administration of 500 T. canis eggs by gastric intubation. In eosinophil counts the values represent
mean ± SEM 3 10
5/ml. Diamonds indicate a significant difference between untreated infected animals and non-infected controls. 
© P< 0.01 and
©© P< 0.01. Asterisks indicate a significant difference between untreated infected guinea-pigs and infected guinea pigs treated once (PrA) or five
times (PrB) with anti-IL-5 Ab. *P < 0.05 and **P < 0.01 and ***P < 0.001.
FIG. 2. BALF and bone marrow IL-8 levels in T. canis infected
guinea-pigs sacrificed on different days post-infection (n= 3
per day). Asterisks indicate a significant difference between
infected (j ) and non-infected (w ) animals. *P< 0.05 and ** P
< 0.01.
FIG. 3. Inhibition of IL-8 release into supernatants of LPS-
stimulated  guinea-pig  adherent  peritoneal  cells  pre-treat-
ment with rIL-5. Data are as means ± SEM (n = 4). Asterisks
indicate differences between the amount of IL-8 released by
LPS-stimulated adherent peritoneal cells pre-incubated with
or without rIL-5, * P< 0.05 and ** P< 0.01. Diamonds indicate
differences in the amount of IL-8 released by LPS-stimulated
adherent  peritoneal  cells  pre-treated  with  rIL-5  in  the
absence or presence of anti-IL-5 Ab, © P < 0.05 and ©© P <
0.01.induced IL-8 release was inhibited by 64% and 66% ,
respectively.  Pre-incubation  of  adherent  cells  with
two  concentration  of  anti-IL-5  Ab  (0.17ng/ml  or
17ng/ml; Fig. 3, columns 3, 4, 6 and 7) prevented the
IL-8 inhibition induced by 10ng/ml of rIL-5 (Fig. 3,
columns 6 and 7) or 0.5ng/ml (Fig. 3, columns 3 and
4). A non-significant increase in IL-8 release followed
the addition of anti-IL-5 Ab (0.17ng/ml or 17.0ng/ml;
Fig.  3,  columns  8  and  9)  to  LPS-stimulated  cells.
However, the addition of rIL-5 or anti-IL-5 Ab to cells
without  LPS  failed  to  induce  IL-8  release  (Fig.  3,
columns 10 and 11). Data are from n = 4 animals.
Discussion
This  study  demonstrated  that  the  inoculation  of
guinea-pigs with T . canis induces a sustained increase
of TNF-a levels in blood, and that the concentration of
blood and BALF IL-8 increases later during infection,
together with the number of circulating eosinophils.
We  demonstrated  previously  that  T .  canis-infected
guinea-pigs present  increased serum  IL-5  levels  fol-
lowed by an increase in eosinophil numbers in blood
and  tissues  which  was  suppressed  by  an  anti-IL-5
Ab.3
TNF-a levels increased very early in the serum of
infected guinea-pigs, reaching levels 87% above those
of noninfected animals 4h after egg inoculation and
remaining above controls  up  to 48 days post-infec-
tion. T . canis larvae persist in different organs for long
periods  of  time  in  infected  animals25 and  release
excretory–secretory  antigens  during  migration  as
demonstrated before.26 The prolonged and sustained
TNF-a activity in blood may thus be explained either
by the persistent presence of larvae in the tissues and/
or  by  the  release  of  those  excretory–secretory
antigens. Moreover, although TNF-a has been descri-
bed as an inflammatory cytokine that appears first in
the circulation in experimental sepsis and endotox-
aemia  and  decreases  a  few  hours  after  the  stim-
ulus,27,28 in  chronic  inflammation,  as  observed  in
mice  injected  with  BCG,29 Paracoccidioides  brasi-
liensis,19 or Schistosoma mansoni eggs,30 TNF-a is
present for a long time post-infection. Moreover, in
patients  with  septic  shock  due  to  various  Gram-
negative bacteria, serum TNF-a remained elevated in
nonsurvivors  who  were  still  alive  at  day  10  after
hospitalization.
31 Thus, the increase of TNF-a levels
for a long period of time is not limited to the present
experimental model.
TNF-a is  involved  in  eosinophil  recruitment21,22
and  has  also  been  reported  to  occur  in  diseases
presenting elevated numbers of eosinophils, such as
airway inflammation.22 Finally, bronchoalveolar leuko-
cytes  from  patients  with  bronchial  asthma  secrete
high  levels of TNF-a .32 The observation  that  serum
and  BALF  IL-8  levels  started  to  increase  only  after
serum  TNF-a release  suggests  that  TNF-a may  be
involved in the induction of IL-8 release in this model.
Indeed, several reports have shown that TNF-a is a
potent IL-8 inducer23,33 and IL-8 is present after TNF-a
therapy in patients with chronic hepatitis.24
The  serum  and  BALF  levels  of  IL-8  in  infected
animals increased significantly only between 6 and 12
days post-infection and peaked between days 18 and
24. These increases occurred at the same time as the
increase in circulating eosinophil numbers, and the
decrease of IL-8 in serum was followed by a reduction
in blood eosinophil counts. Although  blood eosino-
philia in T . canis-infected animals was suppressed by
anti-IL-5 Ab treatment, even when the anti-IL-5 treat-
ment  was  performed  1  day  before  the  peak  of
eosinophilia,3 we may suppose that IL-8 contributed
to eosinophil recruitment. IL-8 has been described as
an  eosinophil  chemoattractant.13,14 However,  it
appears  that  IL-8  is only able  to  induce  eosinophil
migration  after  this  cell  being  primed  by  IL-5.14,34
Also, our results showing that IL-8 release occurs only
outside the bone marrow (Fig. 2), suggest that this
cytokine probably works as an eosinophil chemoat-
tractant  and  contributes  for  the  recruitment  of  IL-
5-primed  eosinophils from  bone  marrow  to  blood.
Based on these data and on the data presented here,
we suggest that IL-8 requires pre-priming with IL-5 to
induce eosinophil recruitment in vivo. Thus, despite
the release of high amounts of IL-8 in this model, the
presence of IL-5 is essential for eosinophil migration,
as  demonstrated  in  antigen-challenged  guinea-pigs6
and  in  vitro.14,34 However,  the  exact  mechanisms
involved  in  this  process  are  not  yet  completely
understood, and further studies using anti-IL-8 Ab will
be essential to determine the contribution of IL-8 to
the  eosinophil  recruitment  and  lung  inflammation
occurring in this model.3
Although TNF-a and IL-8 activities were measured
in serum, BALF and supernatants of adherent perito-
neal cells from guinea-pigs using a human ELISA kit,
we think that  the measurements refer  to authentic
guinea-pig  cytokines  presenting TNF-a and IL-8-like
activities. TNF-a is highly conserved among species35
and supernatants of guinea-pigs adherent peritoneal
cells stimulated with LPS killed 45 ± 6%  of WEHI cells
in a  cytotoxic  assay,  while  supernatants  from  cells
with only medium killed 4 ± 4%  of cells (n = 4; data
not shown); recombinant human IL-8 induces eosino-
phil migration when injected into the skin of guinea-
pigs,13 IL-8 and TNF-a activities were also observed in
the  supernatants  of  guinea-pig  adherent  peritoneal
cells  after  LPS  stimulation,  as  observed  in  human
cells.12,36,37 Moreover,  eosinophil  accumulation  in
guinea-pig skin induced by LPS was inhibited by anti-
TNF-a receptor,21 and serum  IL-8 and TNF-a levels
were decreased in T . canis-infected guinea-pigs trea-
ted with dexamethasone (data not shown).
To better characterize the IL-5/IL-8 interactions we
investigated  the  changes  in  serum TNF-a and  IL-8
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tion by an anti-IL-5 Ab. When IL-5 was thus suppressed
in  infected  animals  eosinophil  counts  were  also
reduced  and  serum  IL-8  levels  increased,  in  the
absence of changes in serum TNF-a (Table 1). These
results suggest that IL-5 downregulates the expression
of IL-8. These in vivo data were confirmed by in vitro
experiments: IL-8 production in the supernatants of
LPS-treated adherent peritoneal cells in the presence
or  not  of  rIL-5  (Fig.  3).  IL-8  release  (Fig.  3)  were
increased by LPS, as reported.37 However, when rIL-5
was added to cells before LPS, a marked inhibition of
IL-8 release occurred, which was prevented by anti-IL-
5 Ab treatment, demonstrating specificity. Also, these
results were corroborated by the findings that rIL-5
added  to  LPS  stimulated  adherent  peritoneal  cell
culture induced significant inhibition of mRNA IL-8
expression which  was  reversed  by  the  addition  of
anti-IL-5 Ab (data not shown).
Thus, the inhibitory effects of IL-5 on IL-8 secretion
may represent an endogenous mechanism of down-
regulating eosinophil inflammation. It may be possi-
ble that IL-5 is required to prevent IL-8 over-produc-
tion and release. Moreover, as discussed above, we
suggest that serum IL-8 acts as an eosinophil chemoat-
tractant in the presence of IL-5. However, since IL-5 is
decreased during the course of infection an increase
in serum IL-8 occurs which, above a certain level, may
act as a modulator of eosinophil release from bone
marrow and tissue eosinophil migration. Thus, it is
possible that the increase of serum IL-8 levels in T .
canis-infected guinea-pigs after anti-IL-5 Ab treatment
contributes  to  the  inhibition  of  eosinophilia.  IL-8,
which is chemotactic for neutrophils, inhibited the
migration of these cells to the skin when administered
at high concentrations by the iv. route.38 On the other
hand,  eosinophils  have  been  described  as  tissue-
resident  cells  that  remain  only a  few  hours  in the
circulation,39 and this characteristic may explain why
we  did  not  find  an  increase  in  blood  eosinophil
counts after anti-IL-5 Ab treatment.
The present results, describing a new function of
IL-5 as a modulator of IL-8 secretion, may be useful for
a better understanding and control of diseases pre-
senting eosinophilia and high IgE levels.1 IL-8 selec-
tively inhibits IgE production40 and may be involved
in the control of serum IgE levels in vivo. Production
of  high  amounts  of  IL-5  in  such  diseases  may
downregulate IL-8 levels and consequently contribute
to the maintenance of high IgE levels during infec-
tion. Thus, an anti-IL-5 Ab treatment might be useful
both  to  inhibit  eosinophil  counts  and  to  increase
serum  IL-8  production  which  down-regulates  IgE
secretion.
In  summary,  the  results  presented  here  demon-
strate that in T . canis-induced eosinophilia there is a
sequential  release  of TNF-a and  IL-8  occurring  in
parallel to or after serum IL-5 release. In this model,
IL-5 appears to be the main factor involved both in the
induction of eosinophilia and in the in vivo control of
IL-8  synthesis  and  production. Thus,  IL-5  may  also
contribute to the increase of IgE synthesis observed in
parasitic  diseases  and  allergy,  in  parallel  to
eosinophilia.
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